We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.29B
AUM Growth
-$264M
Cap. Flow
-$511M
Cap. Flow %
-15.51%
Top 10 Hldgs %
40.48%
Holding
97
New
23
Increased
21
Reduced
21
Closed
30

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$102M
2
AMZN icon
Amazon
AMZN
+$92.7M
3
SCHW
Charles Schwab
SCHW
+$88M
4
BABA icon
Alibaba
BABA
+$82.5M
5
SYF icon
Synchrony
SYF
+$61.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$166M
2
UNH icon
UnitedHealth
UNH
+$151M
3
HCA icon
HCA Healthcare
HCA
+$137M
4
GILD icon
Gilead Sciences
GILD
+$110M
5
LLY icon
Eli Lilly
LLY
+$92.6M

Sector Composition

Rank Sector Weight
1 Healthcare 48.02%
2 Technology 9.28%
3 Industrials 8.23%
4 Financials 7.66%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$124B
$196M 5.97%
2,853,840
+778,063
+37% +$51.4M
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$193M 5.87%
2,267,196
+108,029
+5% +$9.18M
AGN
3
DELISTED
Allergan plc
AGN
$154M 4.68%
492,459
-116,330
-19% -$34.6M
PANW icon
4
Palo Alto Networks
PANW
$279B
$144M 4.38%
4,913,112
+1,674,006
+52% +$48.3M
AER icon
5
AerCap
AER
$23.4B
$126M 3.83%
2,922,514
+828,523
+40% +$34.7M
TEVA icon
6
Teva Pharmaceuticals
TEVA
$36.5B
$122M 3.71%
1,860,952
+322,087
+21% +$19.9M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.24T
$107M 3.25%
+2,750,720
New +$102M
AMZN icon
8
Amazon
AMZN
$2.66T
$99.4M 3.02%
+2,941,200
New +$92.7M
VMC icon
9
Vulcan Materials
VMC
$36.4B
$97.2M 2.95%
1,023,285
+93,385
+10% +$9.05M
EW icon
10
Edwards Lifesciences
EW
$48.9B
$92.7M 2.82%
3,522,294
-1,202,286
-25% -$31.2M
SCHW
11
Charles Schwab
SCHW
$174B
$91.5M 2.78%
+2,779,577
New +$88M
BABA icon
12
Alibaba
BABA
$283B
$85.5M 2.6%
+1,051,826
New +$82.5M
MDCO
13
DELISTED
Medicines Co
MDCO
$77.2M 2.34%
2,066,547
+776,895
+60% +$29.4M
HRTX icon
14
Heron Therapeutics
HRTX
$90.3M
$74.2M 2.25%
2,777,464
-185,192
-6% -$4.95M
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$72.7M 2.21%
2,078,440
-474,447
-19% -$30.6M
JAZZ icon
16
Jazz Pharmaceuticals
JAZZ
$15.3B
$71.9M 2.19%
511,850
+185,848
+57% +$25.8M
UHS icon
17
Universal Health Services
UHS
$9.08B
$68.6M 2.08%
573,905
+56,662
+11% +$6.93M
TXT icon
18
Textron
TXT
$15.8B
$66.1M 2.01%
1,573,009
+1,215,621
+340% +$50.2M
LRCX icon
19
Lam Research
LRCX
$403B
$63.9M 1.94%
+8,048,330
New +$60.5M
ALDR
20
DELISTED
Alder Biopharmaceuticals
ALDR
$62.4M 1.9%
1,890,030
+784,119
+71% +$26.5M
BMY icon
21
CALL
Bristol-Myers Squibb
BMY
$124B
$60.3M 1.83%
877,100
-1,660,000
-65% -$110M
SYF icon
22
Synchrony
SYF
$24.3B
$59.9M 1.82%
+1,969,737
New +$61.7M
AERI
23
DELISTED
Aerie Pharmaceuticals
AERI
$57.8M 1.76%
2,374,797
+156,599
+7% +$3.65M
AET
24
DELISTED
Aetna Inc
AET
$56.6M 1.72%
523,340
-119,575
-19% -$12.9M
ACOR
25
DELISTED
Acorda Therapeutics
ACOR
$55.1M 1.67%
10,729
+3,115
+41% +$13.6M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q4 2015 Portfolio in Review

As of Q4 2015, PFM Health Sciences held 97 positions worth $3.29B, down 7.4% from $3.55B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

PFM Health Sciences withdrew a net $511M in Q4 2015, closing 30 positions and reducing 21 holdings. Its most notable exit was Pfizer, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.

Against the trend, PFM Health Sciences opened a new position in Alphabet (Google) Class A worth $107M.

  • PFM Health Sciences's largest Q4 2015 buy was Alphabet (Google) Class A: 2,750,720 shares worth $107M.
  • PFM Health Sciences added most to Bristol-Myers Squibb in Q4 2015, an estimated $51.4M increase.
  • PFM Health Sciences's biggest Q4 2015 reduction was UnitedHealth, cutting an estimated $151M.
  • PFM Health Sciences fully exited Pfizer in Q4 2015, selling an estimated $166M.
  • PFM Health Sciences's ten largest holdings make up 40% of its $3.29B portfolio in Q4 2015.
  • PFM Health Sciences opened 23 new positions and closed 30 in Q4 2015.
  • PFM Health Sciences's portfolio value fell 7.4% quarter-over-quarter to $3.29B.

Based on PFM Health Sciences's 13F filing for Q4 2015, filed 16 Feb 2016.